產(chǎn)品展示PRODUCTS
BioXCell
更新時(shí)間：2026-01-22
訪問(wèn)量：898
廠商性質(zhì)：代理商
生產(chǎn)地址：
簡(jiǎn)要描述：
BioXCell公司成立于1997年美國(guó)，具有25年以上單克隆抗體和重組蛋白的生產(chǎn)及定制經(jīng)驗(yàn)，可提供高純度、低內(nèi)毒素、無(wú)防腐劑、適用于體內(nèi)臨床前研究的單克隆抗體，是用體內(nèi)抗體金標(biāo)準(zhǔn)
BioXCell公司成立于1997年美國(guó)，具有25年以上單克隆抗體和重組蛋白的生產(chǎn)及定制經(jīng)驗(yàn)，可提供高純度、低內(nèi)毒素、無(wú)防腐劑、適用于體內(nèi)臨床前研究的單克隆抗體，是用體內(nèi)抗體金標(biāo)準(zhǔn)。BioXCell公司專注于提供高品質(zhì)、高效價(jià)、高純度且高性價(jià)比的體內(nèi)用單克隆抗體，為用戶提供全面的抗體靶點(diǎn)與優(yōu)質(zhì)服務(wù)。BioXCell的中和/阻斷/功能性抗體受到國(guó)內(nèi)外研究者的普遍熱愛(ài)和青睞，在免疫、腫瘤/癌癥、神經(jīng)、等方面的研究中的應(yīng)用更是！為您推薦被2018年諾貝爾生理學(xué)或醫(yī)學(xué)獎(jiǎng)得主James P. Allison 傾情推薦的BioXCell，品質(zhì)值得信賴！
BioXCell 特色產(chǎn)品線分為6大系列：
| 類型 | 系列 | 貨號(hào)規(guī)律 |
| 體內(nèi)抗體（經(jīng)典） | InVivoMAbTM | BE-開(kāi)頭 |
| 體內(nèi)抗體（升級(jí)，更高品質(zhì)） | InVivoPlusTM | BP-開(kāi)頭 |
| 生物類似藥 | InVivoSIMTM | SIM-開(kāi)頭 |
| 小鼠或人源化嵌合抗體 | RecombiMAbTM | CP-開(kāi)頭 |
| 專用緩沖液 | InVivoPureTM | IP-開(kāi)頭 |
| 重組融合蛋白 | InVivoMAb/Plus | BE-/BP-開(kāi)頭 |
產(chǎn)品線區(qū)別：InVivoMAbTM VS InVivoPlusTM
| InVivoMAbTM | InVivoPlusTM | |
| 純度 | >95% | >95% |
| 蛋白質(zhì)完整性（通過(guò)SDS PAGE驗(yàn)證） | √ | √ |
| 內(nèi)毒素含量 | <2EU/mg | <1EU/mg |
| WB, FC or ELISA驗(yàn)證 | √ | |
| 蛋白質(zhì)聚集體≤5% | √ | |
| 鼠病原體檢測(cè) （臨床前研究，Pre-Clinical） | √ | |
| 不含疊氮化物和載體蛋白 | √ | √ |
| 大量現(xiàn)貨供應(yīng) | √ | √ |
| 體內(nèi)研究 | √ | √ |
| 貨號(hào)開(kāi)頭 | BE開(kāi)頭 | BP開(kāi)頭 |
| 歸納 | 基礎(chǔ)科研 | 研發(fā)、臨床前/升級(jí)款 |
BioXCell為何如眾不同，優(yōu)勢(shì)：
超過(guò)25年單克隆抗體和重組蛋白生產(chǎn)及定制經(jīng)驗(yàn)
超過(guò)19000篇高質(zhì)量期刊文獻(xiàn)引用
的產(chǎn)品質(zhì)量，1年超長(zhǎng)質(zhì)保
的客戶服務(wù)和技術(shù)支持
從1mg到50g級(jí)，現(xiàn)貨供應(yīng)
性價(jià)比，產(chǎn)品廣泛，卻各個(gè)精品
高純度、低內(nèi)毒素，無(wú)防腐劑，無(wú)載體蛋白，體內(nèi)應(yīng)用選！
沒(méi)有時(shí)間從雜交瘤中培養(yǎng)和純化抗體？ 讓Bio X細(xì)胞來(lái)做吧！BioXCell定制服務(wù)，省心之選：
| 快速周轉(zhuǎn)時(shí)間 | 50mg 以上產(chǎn)量 |
| 超低內(nèi)毒素水平 | InVivoMAb或 InVivoPlus 商業(yè)化產(chǎn)品級(jí)別質(zhì)量 |
| 超高純度 | 細(xì)胞系凍存，與再使用 |
2018年諾貝爾生理學(xué)或醫(yī)學(xué)獎(jiǎng)得主James P. Allison 傾情推薦 Bio X Cell
作為BioXCell在中國(guó)的區(qū)域總代理，科技有限公司將為中國(guó)客戶提供面的BioXCell的產(chǎn)品。下圖為BioXCell公司科技有限公司（AmyJet Scientific Inc.）作為BioXCell在中國(guó)區(qū)域的代理書。
BioXCell產(chǎn)品：
| 貨號(hào) | 產(chǎn)品名稱 | 中文名稱 | 同型對(duì)照 | 稀釋緩沖液 |
| BE0091 | InVivoMAb polyclonal Armenian hamster IgG | InVivoMAb 多克隆亞美尼亞倉(cāng)鼠 IgG | IP0070 | |
| BE0001-2 | InVivoMAb anti-human CD3 | InVivoMAb 抗人 CD3 | BE0085 | IP0070 |
| BE0362 | InVivoMAb anti-human CEACAM 1/3/5/6/8 | InVivoMAb 抗人 CEACAM 1/3/5/6/8 | BE0083 | IP0070 |
| BE0363 | InVivoMAb anti-human CEACAM7 | InVivoMAb 抗人 CEACAM7 | BE0083 | IP0070 |
| BE0368 | InVivoMAb anti-human/ mouse/rat amyloid-beta | InVivoMAb 抗人/小鼠/大鼠淀粉樣蛋白-β | BE0086 | IP0070 |
| BE0378 | InVivoMAb anti-mouse CD16.2 (FcγRIV) | InVivoMAb 抗小鼠 CD16.2 (FcγRIV) | BE0091 | IP0070 |
| BE0360 | InVivoMAb anti-mouse CD24 | InVivoMAb 抗小鼠 CD24 | BE0090 | IP0070 |
| BE0012 | InVivoMAb anti-mouse CD25 (IL-2Rα) | InVivoMAb 抗小鼠 CD25 (IL-2Rα) | BE0088 | IP0070 |
| BE0015-1 | InVivoMAb anti-mouse CD28 | InVivoMAb 抗小鼠 CD28 | BE0087 | IPT060 |
| BE0015-5 | InVivoMAb anti-mouse CD28 | InVivoMAb 抗小鼠 CD28 | BE0091 | IP0070 |
| BE0377 | InVivoMAb anti-mouse CD31 (PECAM-1) | InVivoMAb 抗小鼠 CD31 (PECAM-1) | BE0089 | IP0070 |
| BE0001-1 | InVivoMAb anti-mouse CD3ε | InVivoMAb 抗小鼠 CD3ε | BE0091 | IP0070 |
| BE0003-1 | InVivoMAb anti-mouse CD4 | InVivoMAb 抗小鼠 CD4 | BE0090 | IP0065 |
| BE0119 | InVivoMAb anti-mouse CD4 | InVivoMAb 抗小鼠 CD4 | BE0090 | IP0070 |
| BE0016-2 | InVivoMAb anti-mouse CD40 | InVivoMAb 抗小鼠 CD40 | BE0089 | IP0070 |
| BE0017-1 | InVivoMAb anti-mouse CD40L (CD154) | InVivoMAb 抗小鼠 CD40L (CD154) | BE0091 | IP0070 |
| BE0175 | InVivoMAb anti-mouse CD71 (TfR1) | InVivoMAb 抗小鼠 CD71 (TfR1) | BE0089 | IP0070 |
| BE0024 | InVivoMAb anti-mouse CD80 (B7-1) | InVivoMAb 抗小鼠 CD80 (B7-1) | BE0091 | IP0080 |
| BE0004-1 | InVivoMAb anti-mouse CD8α | InVivoMAb 抗小鼠 CD8α | BE0089 | IP0065 |
| BE0061 | InVivoMAb anti-mouse CD8α | InVivoMAb 抗小鼠 CD8α | BE0090 | IP0070 |
| BE0117 | InVivoMAb anti-mouse CD8α | InVivoMAb 抗小鼠 CD8α | BE0090 | IP0070 |
| BE0213 | InVivoMAb anti-mouse CSF1R (CD115) | InVivoMAb 抗小鼠 CSF1R (CD115) | BE0089 | IP0070 |
| BE0032 | InVivoMAb anti-mouse CTLA-4 (CD152) | InVivoMAb 抗小鼠 CTLA-4 (CD152) | BE0091 | IP0065 |
| BE0131 | InVivoMAb anti-mouse CTLA-4 (CD152) | InVivoMAb 抗小鼠 CTLA-4 (CD152) | BE0087 | IP0070 |
| BE0164 | InVivoMAb anti-mouse CTLA-4 (CD152) | InVivoMAb 抗小鼠 CTLA-4 (CD152) | BE0086 | IP0070 |
| BE0241 | InVivoMAb anti-mouse IFNAR-1 | InVivoMAb 抗小鼠 IFNAR-1 | BE0083 | IP0070 |
| BE0055 | InVivoMAb anti-mouse IFNγ | InVivoMAb 抗小鼠 IFNγ | BE0088 | IPT080 |
| BE0371 | InVivoMAb anti-mouse IL-12 p35 | InVivoMAb 抗小鼠 IL-12 p35 | BE0089 | IP0070 |
| BE0045 | InVivoMAb anti-mouse IL-4 | InVivoMAb 抗小鼠 IL-4 | BE0088 | IP0070 |
| BE0075-1 | InVivoMAb anti-mouse Ly6G | InVivoMAb 抗小鼠 Ly6G | BE0089 | IP0070 |
| BE0075 | InVivoMAb anti-mouse Ly6G/Ly6C (Gr-1) | InVivoMAb 抗小鼠 Ly6G/Ly6C (Gr-1) | BE0090 | IP0070 |
| BE0036 | InVivoMAb anti-mouse NK1.1 | InVivoMAb 抗小鼠 NK1.1 | BE0085 | IP0070 |
| BE0372 | InVivoMAb anti-mouse osteopontin (SPP1) | InVivoMAb 抗小鼠骨橋蛋白 (SPP1) | BE0366 | IP0070 |
| BE0031 | InVivoMAb anti-mouse OX40 (CD134) | InVivoMAb 抗小鼠 OX40 (CD134) | BE0088 | IP0070 |
| BE0033-2 | InVivoMAb anti-mouse PD-1 (CD279) | InVivoMAb 抗小鼠 PD-1 (CD279) | BE0091 | IP0065 |
| BE0146 | InVivoMAb anti-mouse PD-1 (CD279) | InVivoMAb 抗小鼠 PD-1 (CD279) | BE0089 | IP0070 |
| BE0273 | InVivoMAb anti-mouse PD-1 (CD279) | InVivoMAb 抗小鼠 PD-1 (CD279) | BE0089 | IP0070 |
| BE0101 | InVivoMAb anti-mouse PD-L1 (B7-H1) | InVivoMAb 抗小鼠 PD-L1 (B7-H1) | BE0090 | IP0065 |
| BE0353 | InVivoMAb anti-mouse/ human/rat/monkey ICOS (CD278) | InVivoMAb 抗小鼠/人/大鼠/猴 ICOS (CD278) | BE0091 | IP0070 |
| BE0057 | InVivoMAb anti-mouse/ human/rat/monkey/ hamster/canine/bovine TGF-β | InVivoMAb 抗小鼠/人/大鼠/猴/倉(cāng)鼠/犬/牛 TGF-β | BE0083 | IP0070 |
| BE0083 | InVivoMAb mouse IgG1 isotype control, unknown specificity | InVivoMAb 小鼠 IgG1 同種型對(duì)照，特異性未知 | IP0065 | |
| BE0085 | InVivoMAb mouse IgG2a isotype control, unknown specificity | InVivoMAb 小鼠 IgG2a 同種型對(duì)照，特異性未知 | IP0070 | |
| BE0086 | InVivoMAb mouse IgG2b isotype control, unknown specificity | InVivoMAb 小鼠 IgG2b 同種型對(duì)照，特異性未知 | IP0070 | |
| BE0087 | InVivoMAb polyclonal Syrian hamster IgG | InVivoMAb 多克隆敘利亞倉(cāng)鼠 IgG | IP0070 | |
| BE0088 | InVivoMAb rat IgG1 isotype control, anti-horseradish peroxidase | InVivoMAb 大鼠 IgG1 同種型對(duì)照，抗辣根過(guò)氧化物酶 | IP0070 | |
| BE0089 | InVivoMAb rat IgG2a isotype control, anti-trinitrophenol | InVivoMAb 大鼠 IgG2a 同種型對(duì)照，抗 | IP0065 | |
| BE0090 | InVivoMAb rat IgG2b isotype control, anti-keyhole limpet hemocyanin | InVivoMAb 大鼠 IgG2b 同種型對(duì)照，抗鎖孔血藍(lán)蛋白 | IP0070 | |
| BE0099 | InVivoMAb recombinant CTLA-4-Ig (hum/hum) | InVivoMAb 重組 CTLA-4-Ig（人/人-融合蛋白） | BE0096 | IP0070 |
| BE0098 | InVivoMAb recombinant Flt-3L-Ig (hum/hum) | InVivoMAb 重組 Flt-3L-Ig（人/人-融合蛋白） | BE0096 | IP0070 |
| BP0307 | InVivoPlus anti-mouse CD16/CD32 | InVivoPlus 抗小鼠 CD16/CD32 | BP0090 | IP0080 |
| BP0356 | InVivoPlus anti-mouse CD20 | InVivoPlus 抗小鼠 CD20 | BE0366 | IP0070 |
| BP0012 | InVivoPlus anti-mouse CD25 (IL-2Rα) | InVivoPlus 抗小鼠 CD25 (IL-2Rα) | BP0088 | IP0070 |
| BP0001-1 | InVivoPlus anti-mouse CD3ε | InVivoPlus 抗小鼠 CD3ε | BP0091 | IP0070 |
| BP0003-1 | InVivoPlus anti-mouse CD4 | InVivoPlus 抗小鼠 CD4 | BP0090 | IP0065 |
| BP0016-2 | InVivoPlus anti-mouse CD40 | InVivoPlus 抗小鼠 CD40 | BP0089 | IP0070 |
| BP0017-1 | InVivoPlus anti-mouse CD40L (CD154) | InVivoPlus 抗小鼠 CD40L (CD154) | BP0091 | IP0070 |
| BP0004-1 | InVivoPlus anti-mouse CD8α | InVivoPlus 抗小鼠 CD8α | BP0089 | IP0065 |
| BP0061 | InVivoPlus anti-mouse CD8α | InVivoPlus 抗小鼠 CD8α | BP0090 | IP0070 |
| BP0117 | InVivoPlus anti-mouse CD8α | InVivoPlus 抗小鼠 CD8α | BP0090 | IP0070 |
| BP0213 | InVivoPlus anti-mouse CSF1R (CD115) | InVivoPlus 抗小鼠 CSF1R (CD115) | BP0089 | IP0070 |
| BP0032 | InVivoPlus anti-mouse CTLA-4 (CD152) | InVivoPlus 抗小鼠 CTLA-4 (CD152) | BP0091 | IP0065 |
| BP0131 | InVivoPlus anti-mouse CTLA-4 (CD152) | InVivoPlus 抗小鼠 CTLA-4 (CD152) | BP0087 | IP0070 |
| BP0164 | InVivoPlus anti-mouse CTLA-4 (CD152) | InVivoPlus 抗小鼠 CTLA-4 (CD152) | BP0086 | IP0070 |
| BP0241 | InVivoPlus anti-mouse IFNAR-1 | InVivoPlus 抗小鼠 IFNAR-1 | BP0083 | IP0070 |
| BP0055 | InVivoPlus anti-mouse IFNγ | InVivoPlus 抗小鼠 IFNγ | BP0088 | IPT080 |
| BP0045 | InVivoPlus anti-mouse IL-4 | InVivoPlus 抗小鼠 IL-4 | BP0088 | IP0070 |
| BP0075-1 | InVivoPlus anti-mouse Ly6G | InVivoPlus 抗小鼠 Ly6G | BP0089 | IP0070 |
| BP0075 | InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) | InVivoPlus 抗小鼠 Ly6G/Ly6C (Gr-1) | BP0090 | IP0070 |
| BP0036 | InVivoPlus anti-mouse NK1.1 | InVivoPlus 抗小鼠 NK1.1 | BP0085 | IP0070 |
| BP0031 | InVivoPlus anti-mouse OX40 (CD134) | InVivoPlus 抗小鼠 OX40 (CD134) | BP0088 | IP0070 |
| BP0033-2 | InVivoPlus anti-mouse PD-1 (CD279) | InVivoPlus 抗小鼠 PD-1 (CD279) | BP0091 | IP0065 |
| BP0146 | InVivoPlus anti-mouse PD-1 (CD279) | InVivoPlus 抗小鼠 PD-1 (CD279) | BP0089 | IP0070 |
| BP0273 | InVivoPlus anti-mouse PD-1 (CD279) | InVivoPlus 抗小鼠 PD-1 (CD279) | BP0089 | IP0070 |
| BP0101 | InVivoPlus anti-mouse PD-L1 (B7-H1) | InVivoPlus 抗小鼠 PD-L1 (B7-H1) | BP0090 | IP0065 |
| BP0057 | InVivoPlus anti-mouse/human/rat/monkey /hamster/canine/bovine TGF-β | InVivoPlus 抗小鼠/人/大鼠/猴/倉(cāng)鼠/犬/牛 TGF-β | BP0083 | IP0070 |
| BP0089 | InVivoPlus rat IgG2a isotype control, anti-trinitrophenol | InVivoPlus 大鼠 IgG2a 同種型對(duì)照，抗 | IP0065 | |
| BP0099 | InVivoPlus recombinant CTLA-4-Ig (hum/hum) | InVivoPlus 重組 CTLA-4-Ig（人/人-融合蛋白） | IP0070 | |
| IPT060 | InVivoPure pH 6.0T Dilution Buffer | InVivoPure pH 6.0T 稀釋緩沖液 | ||
| IP0065 | InVivoPure pH 6.5 Dilution Buffer | InVivoPure pH 6.5 稀釋緩沖液 | ||
| IP0070 | InVivoPure pH 7.0 Dilution Buffer | InVivoPure pH 7.0 稀釋緩沖液 | ||
| IPT080 | InVivoPure pH 8.0T Dilution Buffer | InVivoPure pH 8.0T 稀釋緩沖液 | ||
| SIM0008 | InVivoSIM anti-human CD20 (Rituximab Biosimilar) | InVivoSIM 抗人 CD20（ 生物類似藥） | BP0297 | IP0070 |
| SIM0004 | InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar) | InVivoSIM 抗人 CTLA-4（伊匹單抗 生物類似藥） | BP0297 | IP0070 |
| SIM0005 | InVivoSIM anti-human HER2 (Trastuzumab Biosimilar) | InVivoSIM 抗人 HER2（ 生物類似藥） | BP0297 | IP0070 |
| SIM0003 | InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) | InVivoSIM 抗人 PD-1（納武單抗 生物類似藥） | CP147 | IP0070 |
| SIM0010 | InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar) | InVivoSIM 抗人 PD-1（帕博利珠單抗 生物類似藥） | CP147 | IP0070 |
| SIM0009 | InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar) | InVivoSIM 抗人 PD-L1（阿替利珠單抗 生物類似藥） | BP0297 | IP0070 |
| SIM0001 | InVivoSIM anti-human TNFα (Adalimumab Biosimilar) | InVivoSIM 抗人 TNFα（阿達(dá)木單抗 生物類似藥） | BP0297 | IP0070 |
| SIM0006 | InVivoSIM anti-human TNFα (Infliximab Biosimilar) | InVivoSIM 抗人 TNFα（英夫利昔單抗 生物類似藥） | BP0297 | IP0070 |
| SIM0007 | InVivoSIM anti-human VEGF (Bevacizumab Biosimilar) | InVivoSIM 抗人 VEGF（貝伐珠單抗 生物類似藥） | BP0297 | IP0070 |
*以上產(chǎn)品科研用途，不得直接用于臨床與醫(yī)療. 更多BioXCell產(chǎn)品手冊(cè)，歡迎垂詢中國(guó)區(qū)總代理，科技：
作為BioXCell在中國(guó)的區(qū)域總代理，科技有限公司將為中國(guó)客戶提供面的BioXCell產(chǎn)品以及客戶訂制化服務(wù)。歡迎大家隨時(shí)聯(lián)系我們。
上一篇： Nordic BioSite
下一篇：ELISA Systems
產(chǎn)品中心
Products
相關(guān)文章
客服微信掃一掃